Related Experiment Video
Updated: Apr 17, 2026

07:08
A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
Published on: June 6, 2025
798
National decline in donor heart utilization with regional variability: 1995-2010.
K K Khush1, J G Zaroff, J Nguyen
1Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA.
Summary
Donor heart acceptance for transplantation decreased significantly from 1995 to 2006, influenced by donor characteristics. Improving acceptance rates requires evidence-based criteria and addressing regional variations in organ utilization.
Area of Science:
- Transplantation Medicine
- Cardiology
- Public Health
Background:
- End-stage heart disease presents a growing challenge due to a severe shortage of donor hearts.
- Limited donor heart availability restricts transplantation options for eligible patients.
- Understanding donor heart acceptance trends is crucial for optimizing organ utilization.
Purpose of the Study:
- To analyze national trends in donor heart acceptance for transplantation.
- To identify demographic and clinical factors influencing donor heart acceptance.
- To examine regional variations in donor heart utilization.
Main Methods:
- Analysis of data from the Organ Procurement and Transplantation Network (OPTN) for adult cardiac donors (1995-2010).
- Categorization of donor heart disposition: transplanted, declined, or other uses.
- Statistical examination of changes in acceptance probability based on donor characteristics and UNOS region.
Main Results:
- Out of 82,053 potential donor hearts, 34% were accepted, 48% declined, and 18% used otherwise.
- Donor heart acceptance declined from 44% in 1995 to 29% in 2006, then rose to 32% in 2010.
- Older donor age, female sex, and medical comorbidities were associated with non-acceptance, with increasing prevalence of these factors over time.
Conclusions:
- Donor heart acceptance rates have fluctuated, impacted by donor demographics and health status.
- While predictors of non-acceptance are consistent across regions, utilization rates vary, suggesting room for improvement.
- Evidence-based criteria and targeted regional strategies are needed to enhance donor heart acceptance and transplantation rates.
Related Concept Videos
Imbalances in Cardiac Output
3.5K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.5K
Kidney Transplant I: Introduction
782
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
782
Cardiomyopathy II: Dilated Cardiomyopathy
805
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
805

